A Patent Before the First Trial
pricing
What this case is about
Your client is Briarwell Pharmaceuticals, a U.S.-based drugmaker considering the sale of a patent for a molecule it has developed. The pill has not launched, and the client wants to understand its economic value before deciding what to do.
Objective
Estimate the molecule’s commercial economics, probability-weight the clinical trial outcomes, and recommend whether to accept the buyer’s offer while flagging material risks not included in the estimate.
Skills this case tests
Structuring the problem
Working the numbers
Judgement and recommendation
Communicating clearly
This is an interview practice scenario. Figures in the brief are case inputs, not current market research.